135 related articles for article (PubMed ID: 12359773)
1. An in vitro tumor model: analysis of angiogenic factor expression after chemotherapy.
Keyes K; Cox K; Treadway P; Mann L; Shih C; Faul MM; Teicher BA
Cancer Res; 2002 Oct; 62(19):5597-602. PubMed ID: 12359773
[TBL] [Abstract][Full Text] [Related]
2. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
[TBL] [Abstract][Full Text] [Related]
3. LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.
Keyes KA; Mann L; Sherman M; Galbreath E; Schirtzinger L; Ballard D; Chen YF; Iversen P; Teicher BA
Cancer Chemother Pharmacol; 2004 Feb; 53(2):133-40. PubMed ID: 14593497
[TBL] [Abstract][Full Text] [Related]
4. Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: predominance of vascular endothelial growth factor.
Campbell CL; Savarese DM; Quesenberry PJ; Savarese TM
Int J Cancer; 1999 Mar; 80(6):868-74. PubMed ID: 10074920
[TBL] [Abstract][Full Text] [Related]
5. Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth.
Furumatsu T; Nishida K; Kawai A; Namba M; Inoue H; Ninomiya Y
Int J Cancer; 2002 Jan; 97(3):313-22. PubMed ID: 11774282
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Fontanini G; Cuccato S; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2001 May; 7(5):1459-65. PubMed ID: 11350918
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts.
Berse B; Hunt JA; Diegel RJ; Morganelli P; Yeo K; Brown F; Fava RA
Clin Exp Immunol; 1999 Jan; 115(1):176-82. PubMed ID: 9933439
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
[TBL] [Abstract][Full Text] [Related]
9. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.
Benckert C; Jonas S; Cramer T; Von Marschall Z; Schäfer G; Peters M; Wagner K; Radke C; Wiedenmann B; Neuhaus P; Höcker M; Rosewicz S
Cancer Res; 2003 Mar; 63(5):1083-92. PubMed ID: 12615726
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia.
Chou JM; Li CY; Tefferi A
Leuk Res; 2003 Jun; 27(6):499-504. PubMed ID: 12648509
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
[TBL] [Abstract][Full Text] [Related]
14. TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids.
Wen FQ; Liu X; Manda W; Terasaki Y; Kobayashi T; Abe S; Fang Q; Ertl R; Manouilova L; Rennard SI
J Allergy Clin Immunol; 2003 Jun; 111(6):1307-18. PubMed ID: 12789234
[TBL] [Abstract][Full Text] [Related]
15. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.
Brogi E; Wu T; Namiki A; Isner JM
Circulation; 1994 Aug; 90(2):649-52. PubMed ID: 8044933
[TBL] [Abstract][Full Text] [Related]
16. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.
Ryuto M; Ono M; Izumi H; Yoshida S; Weich HA; Kohno K; Kuwano M
J Biol Chem; 1996 Nov; 271(45):28220-8. PubMed ID: 8910439
[TBL] [Abstract][Full Text] [Related]
17. Cell density regulates thrombospondin-1 production in malignant glioma cells.
Naganuma H; Satoh E; Kawataki T; Amagasaki K; Satoh H; Nukui H
J Neurooncol; 2003 Jun; 63(2):147-53. PubMed ID: 12825818
[TBL] [Abstract][Full Text] [Related]
18. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
Zhang H; Issekutz AC
Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924
[TBL] [Abstract][Full Text] [Related]
19. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
